Showing results (11-20 of 310) with videos related to

Sort By:
Pageof 31
Biochemical Pharmacology|January 13, 1994
Drug-metabolizing enzymes in ligand-modulated transcriptionD W Nebert
European Journal of Pharmacology|January 3, 2001
Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogeneticsD W Nebert
Mutation Research|April 1, 1991
Role of genetics and drug metabolism in human cancer riskD W Nebert
EXS|January 1, 1994
Drug metabolism and signal transduction: possible role of Ah receptor and arachidonic acid cascade in protection from ethanol toxicityD W Nebert
Toxicology and Applied Pharmacology|June 1, 2001
Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxinA G Smith, B Clothier, P Carthew, et al.
IARC Scientific Publications|January 1, 1982
Pharmacogenetics and human cancerD W Nebert
Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement|January 1, 1980
The Ah locus. A gene with possible importance in cancer predictabilityD W Nebert
Pharmacogenetics|June 22, 2000
Suggestions for the nomenclature of human alleles: relevance to ecogenetics, pharmacogenetics and molecular epidemiologyD W Nebert
Clinical Genetics|January 15, 2000
Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?D W Nebert
Molecular Endocrinology (Baltimore, Md.)|September 1, 1991
Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functionsD W Nebert
Pageof 31